BOSTON, MA, Labviva, announced that it has secured $20 million in Series A financing led by Biospring Partners.
Labviva, the AI-driven life sciences digital marketplace that simplifies and scales purchasing processes, announced that it has secured $20 million in Series A financing led by Biospring Partners, with participation from existing investors Senator Investment Group, B Capital Group, and Glasswing Ventures. The Series A funding brings the total amount raised since inception to $30 million.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.